IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MERONI, PIERLUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 21.902
NA - Nord America 18.821
AS - Asia 15.518
SA - Sud America 1.827
AF - Africa 299
OC - Oceania 80
Continente sconosciuto - Info sul continente non disponibili 15
Totale 58.462
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.163
GB - Regno Unito 8.187
CN - Cina 5.835
SG - Singapore 3.894
IT - Italia 3.059
DE - Germania 2.237
RU - Federazione Russa 1.988
SE - Svezia 1.857
HK - Hong Kong 1.574
BR - Brasile 1.251
TR - Turchia 996
IE - Irlanda 818
IN - India 787
KR - Corea 775
FR - Francia 772
UA - Ucraina 721
NL - Olanda 717
VN - Vietnam 567
FI - Finlandia 553
CA - Canada 453
EU - Europa 412
ID - Indonesia 260
JP - Giappone 253
CO - Colombia 244
ES - Italia 172
PL - Polonia 164
MX - Messico 142
AR - Argentina 125
GR - Grecia 109
BE - Belgio 92
DK - Danimarca 89
BD - Bangladesh 85
CI - Costa d'Avorio 85
AT - Austria 67
AU - Australia 66
CH - Svizzera 59
IQ - Iraq 57
IR - Iran 51
CL - Cile 49
EC - Ecuador 47
UZ - Uzbekistan 47
SA - Arabia Saudita 45
TW - Taiwan 45
ZA - Sudafrica 40
PH - Filippine 39
RO - Romania 35
EG - Egitto 31
MA - Marocco 31
PK - Pakistan 30
VE - Venezuela 30
PE - Perù 29
PT - Portogallo 29
TH - Thailandia 25
MY - Malesia 23
IL - Israele 19
BO - Bolivia 18
UY - Uruguay 18
KE - Kenya 17
NO - Norvegia 17
DZ - Algeria 16
HR - Croazia 16
HU - Ungheria 16
LT - Lituania 16
RS - Serbia 16
TN - Tunisia 16
CZ - Repubblica Ceca 15
AE - Emirati Arabi Uniti 14
BG - Bulgaria 14
BY - Bielorussia 14
PY - Paraguay 14
NZ - Nuova Zelanda 13
OM - Oman 11
LU - Lussemburgo 10
DO - Repubblica Dominicana 9
JM - Giamaica 9
NP - Nepal 9
AZ - Azerbaigian 8
KZ - Kazakistan 8
SK - Slovacchia (Repubblica Slovacca) 8
ET - Etiopia 7
GE - Georgia 7
HN - Honduras 7
LB - Libano 7
NG - Nigeria 7
TT - Trinidad e Tobago 7
UG - Uganda 7
AL - Albania 6
CR - Costa Rica 6
EE - Estonia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
JO - Giordania 5
KG - Kirghizistan 5
MD - Moldavia 5
PS - Palestinian Territory 5
SC - Seychelles 5
SI - Slovenia 5
AM - Armenia 4
BB - Barbados 4
CU - Cuba 4
LK - Sri Lanka 4
Totale 58.770
Salva come PNG Salva come JPEG
Città #
Southend 7.635
Singapore 2.188
Chandler 1.753
Hong Kong 1.502
Seattle 1.428
Ashburn 1.307
Beijing 1.252
Princeton 1.088
Milan 995
Wilmington 851
Dublin 804
Dallas 759
Council Bluffs 659
Ann Arbor 520
Redmond 518
Fairfield 473
Jacksonville 462
Hangzhou 451
Santa Clara 443
Mountain View 426
Bengaluru 425
Nanjing 421
Des Moines 396
Dearborn 366
Los Angeles 361
Hanover 348
Sakarya 341
Toronto 312
Woodbridge 303
Frankfurt am Main 296
Buffalo 288
Moscow 272
Houston 266
Boardman 235
Guangzhou 232
Shanghai 223
Serra 215
Redwood City 202
Bogotá 199
Somerville 195
Andover 191
Columbus 178
The Dalles 173
Hefei 172
Cangzhou 166
Sunnyvale 165
Grafing 164
Dong Ket 160
Jinan 160
New York 156
Cambridge 150
Shenyang 146
Phoenix 144
Tokyo 130
Jakarta 119
Hebei 114
São Paulo 112
Eitensheim 106
Changsha 104
Tianjin 102
Munich 101
Nanchang 100
Warsaw 93
Ho Chi Minh City 87
Helsinki 86
Athens 84
Rome 84
Abidjan 83
Berlin 83
Zhengzhou 83
Jiaxing 76
Pisa 76
Hanoi 70
Brussels 67
Fuzhou 66
San Diego 66
Shenzhen 58
Chicago 57
Hamburg 56
London 54
Bitonto 52
Istanbul 52
Seoul 51
Ottawa 49
Madrid 48
Falls Church 47
Kunming 47
Wuhan 44
Nuremberg 42
Tashkent 37
Fremont 36
Taizhou 35
Haikou 34
Mumbai 34
Norwalk 34
Redondo Beach 33
Curitiba 32
Washington 32
Brooklyn 30
Florence 30
Totale 36.651
Salva come PNG Salva come JPEG
Nome #
Management of Thrombotic Antiphospholipid Syndrome 742
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 622
The X chromosome and the sex ratio of autoimmunity 553
The role of environmental estrogens and autoimmunity 546
Complement activation in anti-phospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery 455
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) 437
Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases 378
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment : relationships with endothelial function, coagulation and inflammation 339
Inflammatory response and the endothelium 315
Antiphospholipid Antibodies and Infertility : A Gene Expression Study in Decidual Stromal Cells 303
X chromosome monosomy : a common mechanism for autoimmune diseases 298
Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis 293
Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation 287
Blood cell-bound C4d as a marker of complement activation in patients with the antiphospholipid syndrome 285
Cerebrospinal fluid phosphorylated neurofilament heavy chain and chitotriosidase in primary lateral sclerosis 283
Thromboprophylaxis in carriers of antiphospholipid antibodies (APL) without previous thrombosis : "Pros" and "Cons" 277
Pidotimod : a reappraisal 270
mTOR as a multifunctional therapeutic target in HIV infection 268
Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6 256
Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis : effects of tumor necrosis factor-alpha blockade 256
Anti-beta 2 glycoprotein I antibodies in centenarians 249
L’aumento del drive simpatico che si osserva durante bypass aortocoronarico correla con l’espressione delle citochine proinfiammatorie ed é attenuato dalla terapia betabloccante 247
Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1 : prevalence in systemic lupus erythematosus 245
X monosomy in female systemic lupus erythematosus 242
Circulating stem cell factor in patients with chronic idiopathic urticaria 238
Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome : evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients 238
Complement activation and endothelial perturbation parallel COVID-19 severity and activity 234
Prolactin's role in the pathogenesis of the antiphospholipid syndrome 231
Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers 230
Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis 223
Treatment of Thrombotic Antiphospholipid Syndrome : The Rationale of Current Management - An Insight into Future Approaches 221
Primary biliary cirrhosis and Sjögren's syndrome : autoimmune epithelitis 214
Anti-inflammatory and immunosuppressive drugs and reproduction 209
Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers 205
Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants 204
Complement activation in patients with COVID-19: a novel therapeutic target 204
Protective effect of a synthetic peptide mimicking the b2GPI PL-binding site on aPL-induced placental damage 201
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment : relationships with endothelial function, coagulation and inflammation 198
Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus 198
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis : A EUSTAR analysis 192
IL-10-producing forkhead box protein 3-negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus 191
Beta-endorphin content in HIV-infected HuT78 cell line and in peripheral lymphocytes from HIV-positive subjects 188
TLR-4 and Annexin A2 Involvement in endothelial cell activation by anti-phospholipid antibodies : specific silencing by small interfering RNAs 188
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 188
A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis : the interferon-inducible gene IFI16 186
Effetto della terapia con infliximab sui marcatori di infiammazione, coagulazione e fibrinolisi nell’artrite reumatoide 183
The geoepidemiology of autoimmune liver disease 183
Up-date on the antiphospholipid syndrome 182
The chemokine scavenger receptor D6 protects the fetus from inflammation-induced abortion 181
Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 179
Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years 177
Patients with antiphospholipid syndrome display endothelial perturbation 175
Association between clinical features and inflammatory gene SNPs in APS 175
L’evoluzione da sindrome da anticorpi antifosfolipidi primaria a lupus eritematoso sistemico : possono gli anticorpi anti-nucleosomi essere predittivi? 174
Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis 173
Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients 172
Updating on the pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss 171
Anti-phospholipid induced murine fetal loss : novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss 171
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor 169
Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs : an Italian multicentre study 169
Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells 168
Measuring IgA anti-β2-glycoprotein I and IgG/IgA anti-domain I antibodies adds value to current serological assays for the antiphospholipid syndrome 168
The Risk of Obstetric Complications and the Effects of Treatment in Women with Low Titer and Medium-High Titer Anti-Phospholipid Antibodies 168
Anti-phospholipid antibody mediated fetal loss : still an open question from a pathogenic point of view 167
ANA screening : an old test with new recommendations 166
Antiphospholipid antibodies and the antiphospholipid syndrome : pathogenic mechanisms 165
Endothelium as a target for antiphospholipid antibodies 164
Mechanisms of action of antiphospholipid antibodies 164
Systemic Lupus erythematosus complicated by thrombotic thrombocytopenic purpura 164
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study 163
Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers 162
Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays : an Italian multicentre study 162
T cell defect in essential mixed cryoglobulinaemia 162
The role of superoxide anion generation in antibody-dependent polymorphonuclear leukocyte-mediated cytotoxicity 161
Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis : report of a family with multiple anti-phospholipid positive members 160
Antiphospholipid antibodies and ex-vivo endothelial perturbation 159
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 159
The detection of lupus anticoagulants in hemophiliacs : the need for different assay systems 158
Rheumatoid arthritis : a female challenge 158
Statins and autoimmune diseases 156
Autoimmunity and anti-TNF-alpha agents 156
Assessment of musculoskeletal hand involvement in systemic sclerosis using ultrasonography and plain radiography 156
Antiphospholipid syndrome and systemic lupus erythematosus patients: what's new about cognitive involvement? 155
Juvenile idiopathic arthritis in adulthood : evaluation of disease activity, damage and quality of life 155
Anti-DNA antibodies : a diagnostic and prognostic tool for systemic lupus erythematosus? 154
Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2-glycoprotein i domain 1 and domain 4/5 : ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome 154
Peripheral blood mononuclear cell beta-endorphin concentration is decreased in Chronic Fatigue Syndrome and Fibromyalgia but not in Depression: Preliminary report 152
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study 152
Usefulness of cardiovascular biomarkers and cardiac imaging in systemic rheumatic diseases 152
Anti-NR2 antibodies and primary antiphospholipid syndrome : a preliminary study 152
The long-term prognosis of renal transplantation in patients with lupus nephritis 150
Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicenter retrospective follow-up study 150
Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block : an Italian multicentre cross-sectional study on behalf of the "Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group" 150
Anti-beta-2 glycoprotein I antibodies affect Bcl-2 and Bax trophoblast expression without evidence of apoptosis. 149
Prevalence of autoantibodies against structure specific recognition protein 1 in systemic lupus erythematosus 149
Toll-like receptors : another player in the pathogenesis of the anti-phospholipid sindrome 149
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus 149
Counseling on family planning and contraception in patients with rheumatic diseases : Analysis of 324 patient-reported questionnaires from a multicenter Italian study 149
Hand impairment in systemic sclerosis : association of different hand indices with organ involvement 148
The Efficacy of Treatment with Low Dose Aspirin and Low Molecular Weight Heparin in Pregnant Women with Criteria Anti-Phospholipid Antibodies 148
Totale 21.744
Salva come PNG Salva come JPEG
Categoria #
all - tutte 174.044
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.044
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.145 0 0 0 0 512 458 259 292 627 271 1.320 406
2021/20224.662 396 177 123 194 323 256 456 288 539 478 397 1.035
2022/20236.277 881 586 530 773 637 1.323 112 423 576 73 251 112
2023/20243.665 118 314 204 238 968 267 99 177 79 215 445 541
2024/20259.442 402 1.099 228 856 775 391 339 1.066 533 756 907 2.090
2025/20267.474 1.773 1.026 2.400 1.578 697 0 0 0 0 0 0 0
Totale 62.271